Uterine extracellular matrix components are altered during defective decidualization in interleukin-11 receptor α deficient mice by White, Christine A et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
Reproductive Biology and 
Endocrinology
Open Access Research
Uterine extracellular matrix components are altered during 
defective decidualization in interleukin-11 receptor α deficient mice
Christine A White*1,2, Lorraine Robb3 and Lois A Salamonsen1,2
Address: 1Prince Henry's Institute of Medical Research, Clayton, Victoria 3168, Australia, 2Dept of Obstetrics & Gynaecology, Monash University, 
Clayton, Victoria 3168, Australia and 3Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3001, Australia
Email: Christine A White* - christine.white@phimr.monash.edu.au; Lorraine Robb - robb@wehi.edu.au; 
Lois A Salamonsen - lois.salamonsen@phimr.monash.edu.au
* Corresponding author    
Abstract
Background:  Implantation of the embryo and successful pregnancy are dependent on the
differentiation of endometrial stromal cells into decidual cells. Female interleukin-11 receptor α
(IL-11Rα) deficient mice are infertile due to disrupted decidualization, suggesting a critical role for
IL-11 and its target genes in implantation. The molecular targets of IL-11 in the uterus are unknown,
but it is likely that IL-11 signaling modifies the expression of other genes important in
decidualization. This study aimed to identify genes regulated by IL-11 during decidualization in
mouse uterus, and to examine their expression and localization as an indication of functional
significance during early pregnancy.
Methods: Decidualization was artificially induced in pseudopregnant wild type (IL11Ra+/+) and IL-
11Rα deficient (IL11Ra-/-) littermates by oil injection into the uterine lumen, and gene expression
analyzed by NIA 15K cDNA microarray analysis at subsequent time points. Quantitative real-time
RT-PCR was used as an alternative mRNA quantitation method and the expression and cellular
localization of the protein products was examined by immunohistochemistry.
Results: Among 15,247 DNA probes, 13 showed increased and 4 decreased expression in IL11Ra-
/- uterus at 48 h of decidualization. These included 4 genes encoding extracellular matrix proteins;
collagen III α1, secreted acidic cysteine-rich glycoprotein (SPARC), biglycan and nidogen-1
(entactin). Immunohistochemistry confirmed increased collagen III and biglycan protein expression
in IL11Ra-/- uterus at this time. In both IL11Ra-/- and wild type uterus, collagen III and biglycan were
primarily localized to the outer connective tissue and smooth muscle cells of the myometrium, with
diffuse staining in the cytoplasm of decidualized stromal cells.
Conclusion: These data suggest that IL-11 regulates changes in the uterine extracellular matrix
that are necessary for decidualization.
Background
Implantation of the embryo, formation of the placenta
and successful pregnancy are dependent on the prolifera-
tion and differentiation of endometrial stromal cells into
decidual cells. Decidualization occurs in response to
endometrial and embryonic signals and is thought to
involve complex interactions between ovarian steroid
hormones, the uterine extracellular matrix (ECM), growth
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factors and cytokines (reviewed in [1]). When implanta-
tion is initiated at day 3.5 of pregnancy in the mouse (plug
is day 0), decidualization begins adjacent to the embryo
on the antimesometrial side of the uterus to form the pri-
mary decidual zone [2]. Decidual transformation then
extends mesometrially to form the secondary decidual
zone by day 6, accompanied by a dramatic increase in vas-
cular permeability [3]. The endometrial response to
implantation can be induced artificially by the applica-
tion of oil into the lumen of the hormonally primed
uterus, producing a deciduoma [4]. Natural and artificial
decidualization share many of the same features, with dis-
tinct decidual zones [5], and the progression of each
response can be monitored by an increase in uterine
weight [6].
Female mice with a null mutation in the gene encoding
interleukin-11 receptor α (IL-11Rα) are infertile due to
disrupted decidualization [7], suggesting a critical role for
IL-11 and its target genes in the decidual response. Despite
normal estrous cycles and no detectable ovarian defects,
female IL-11Rα deficient (IL11Ra-/-) mice are unable to
support implantation of either IL11Ra-/-  or wild type
embryos. The failure of decidualization between days 4.5
and 10.5 in IL11Ra-/- females is characterized by greatly
reduced vascular permeability at implantation sites, areas
of hemorrhage, impaired secondary decidual zone forma-
tion, absence of mesometrial decidualization and aber-
rant infiltration of trophoblast giant cells [7]. Although
morphologically similar to the decidua of pregnancy, a
minority of artificially induced deciduomata in IL11Ra-/-
mice show some mesometrial decidualization. Females
homozygous for a hypomorphic IL-11Rα allele also show
reduced decidualization, with decreased cell proliferation,
progressive degeneration of the deciduae, infiltration of
trophoblast giant cells and absence of placental formation
[8]. Neither of these mutations have been found to cause
hematopoietic defects [8,9].
Interleukin-11 is a multifunctional cytokine, initially
described as a bone marrow stroma-derived hematopoi-
etic growth factor [10]. IL-11 shares many functions with
other members of the IL-6 family of cytokines, including
the induction of acute phase proteins [11], inhibition of
adipogenesis [12] and the regulation of bone ECM metab-
olism via induction of tissue inhibitor of metalloprotein-
ases (TIMP)-1 [13]. Like IL-6, leukemia inhibitory factor
(LIF), oncostatin M, ciliary neurotrophic factor and cardi-
otrophin-1, IL-11 exerts its biological effects via a multi-
subunit receptor complex involving the signal transducer
gp130 [14]. Following the formation of its hexameric
receptor composed of two molecules each of IL-11, the
low-affinity ligand-binding IL-11Rα and gp130 [15], IL-
11 is capable of activating a number of downstream sign-
aling pathways. In most cell types, IL-11-activated gp130
mediates its effects through Janus tyrosine kinases (JAKs1-
3 and Tyk2) and the signal transducers and activators of
transcription (STATs1-6) (reviewed in [16]). The rate of
transcription of target genes is then modified by binding
of activated STAT dimers to a DNA element in the pro-
moter region. IL-11 signaling can also control the initia-
tion of translation via sequential activation of PI3-K, Pdk-
1/Akt, p70 S6 kinase and ribosomal protein S6 [17].
Localization and expression of IL-11, IL-11Rα and gp130
in human endometrium across the menstrual cycle sug-
gests a role for this cytokine in decidual transformation in
preparation for pregnancy [18-20]. Levels of immunore-
active IL-11 are highest during the secretory phase of the
cycle, when the endometrium is receptive to implanta-
tion, and IL-11 is produced by the decidualized stromal
cells. Treatment of human endometrial stromal cells in
culture with recombinant human IL-11 increases their
secretion of the decidual markers prolactin and insulin-
like growth factor binding protein (IGFBP)-1, and is asso-
ciated with enhanced differentiation [21]. Plasma levels of
IL-11 are decreased in women with first trimester sponta-
neous abortion [22], and there is decreased expression of
IL-11 protein in chorionic villi and decidua from anem-
bryonic compared to normal pregnancy [23].
The molecular targets of IL-11 in the uterus are unknown,
but it is likely that IL-11 signaling modifies the expression
of other genes important in decidualization. This study
aimed to identify genes regulated by IL-11 during decidu-
alization by cDNA microarray, and to examine their
expression and localization by immunohistochemistry, as
an indication of functional significance during early
pregnancy.
Methods
Animals
Mice deficient in IL-11 receptor α (IL11Ra-/-) had been
previously generated by gene targeting, and serially
crossed more than 10 generations onto a C57BL/6 back-
ground [9]. Heterozygotes were interbred to produce
wild-type (IL11Ra+/+) and IL-11Rα deficient (IL11Ra-/-)
mice, which were identified by Southern blot analysis of
genomic DNA obtained from tail biopsies [9]. All mice
were housed in conventional conditions, fed and watered
ad libitum and maintained in a 12-h light, 12-h dark
cycle. All procedures were approved by the Monash Med-
ical Centre (B) Animal Ethics Committee (AEC# MMCB
2001/04), and were carried out in compliance with the
Helsinki Declaration.
Artificial decidualization
Surgery was performed under xylazine/ketamine-induced
anesthesia, by intraperitoneal administration of 10 mg/kg
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Laboratories, Smithfield, NSW, Australia) and 80 mg/kg
ketamine hydrochloride (Ketalar, Pfizer, West Ryde, NSW,
Australia) in sterile phosphate-buffered saline (PBS).
Anesthesia was reversed with 250 µg yohimbine hydro-
chloride and 400 µg 4-amino pyridine (Reverzine S.A.,
Parnell Laboratories, Alexandria, NSW, Australia) in ster-
ile PBS.
Female IL11Ra+/+ and IL11Ra-/- littermates at 8–12 weeks
of age (n = 4 per genotype per time point) were mated
with wild type vasectomized males to induce pseudopreg-
nancy, with the day of plug detection designated day 0. At
approximately 1400 h on day 3, decidualization was
induced throughout both uterine horns of each animal by
injection of 20 µl of sesame oil (Sigma Chemical Co., St
Louis, MO) into the lumen of each uterine horn via a 26-
gauge needle inserted just distal to the utero-tubal junc-
tion. Mice were necropsied prior to surgery (0 h) or at 18
h, 24 h or 48 h following artificial decidualization. These
time points prior to the onset of secondary decidualiza-
tion were chosen to ensure similar cellular composition of
the IL11Ra+/+ and IL11Ra-/- uteri. Whole uteri were cleaned
of fat and weighed. A section of each uterus was either
fixed in 10% phosphate-buffered formalin overnight or
Carnoy's fixative for 2 h and processed to paraffin wax, or
snap frozen in liquid nitrogen for subsequent RNA
isolation.
Statistical analysis of uterine weight data
The wet weights of whole uterus from IL11Ra+/+ (n = 4/
time point) and IL11Ra-/- (n = 4/time point) mice were
statistically analyzed using GB-Stat 6.5 (Dynamic Micro-
systems, Inc., Silver Spring, MD). Following Bartlett's test
for homogeneity of variance, uterine weight was used as
the dependent variable and genotype and time as the two
independent variables in a two factor analysis of variance.
Bonferroni multiple comparison testing was used to com-
pare uterine weight across time in each genotype and
between genotypes at each time point. A two-tailed p
value of less than 0.05 was considered a significant
difference.
RNA preparation, cDNA microarray hybridization and 
data collection
Total RNA was extracted from whole uterus by acid gua-
nidinium thiocyanate-phenol-chloroform extraction [24],
incorporating an additional chloroform purification step
to remove contaminating phenol. RNA was then treated
with ribonuclease (RNase)-free deoxyribonuclease
(DNase; Ambion, Austin, TX) to remove genomic DNA.
The concentration of RNA in the final preparation was
determined spectrophotometrically, and RNA quality
evaluated by gel electrophoresis (1.2% agarose; Roche
Applied Science, Penzberg, Germany) and by the ratio of
optical density (OD260:OD280 = 1.8–2.0). Each artificially
decidualized IL11Ra+/+ or IL11Ra-/- uterus was processed
individually for microarray hybridization. A reference
pool of RNA was prepared from wild type unstimulated
uteri (n = 16). The experimental design used indirect com-
parisons between IL-11Ra+/+ or IL11Ra-/- and the reference
pool.
Total RNA (10 µg) served as a template for the synthesis
of aminoallyl-cDNA, which was then coupled to a fluores-
cent dye ester (Cy3 or Cy5) as described by the manufac-
turers of the CyScribe cDNA Post Labelling Kit
(Amersham Biosciences, Buckinghamshire, England).
Microcon-30 size exclusion columns (Millipore, Billerica,
MA) were used to initially concentrate RNA samples, and
to purify the cDNA probes prior to and following the dye-
coupling reaction. Slides were printed with sequence-ver-
ified duplicate spots of the NIA 15K cDNA clone set [25]
at the Australian Genome Research Facility and prehybrid-
ized for 30 min at 42 C in 10 mg/ml bovine serum albu-
min (BSA, ICN Biomedicals, Aurora, OH), 25%
formamide (BDH Laboratory Supplies, Poole, England), 5
× SSC (750 mM sodium chloride, 75 mM sodium citrate;
BDH Chemicals/AnalaR, Kilsyth, Victoria, Australia) and
0.1% sodium dodecyl sulfate (SDS; BDH Chemicals/
AnalaR). IL11Ra+/+ or IL11Ra-/- cDNA (Cy3) and reference
cDNA (Cy5) were competitively hybridized to the micro-
arrays in the presence of 1 mg/ml Cot1 DNA (Gibco-BRL,
Life Technologies, Mount Waverley, Australia), 10 mg/ml
salmon sperm DNA (Gibco-BRL) and 10 mg/ml polyade-
nylic acid (Sigma). Hybridizations were repeated using
the alternate dye combinations to account for differential
fluorescent dye incorporation. After washing, slides were
scanned using an Axon GenePix 4000B microarray reader
(Axon Instruments, Union City, CA) and GenePix Pro 4.0
software (Axon Instruments) to generate pairs of 16-bit
tagged image file format (TIFF) files. Following manual
quality control for hybridization artefacts, red (Cy5) and
green (Cy3) mean foreground and median background
fluorescence intensity measurements for each spotted
DNA sequence were extracted for export to the statistical
programming environment R 1.5.1.
Microarray data analysis
Differential gene expression between IL11Ra+/+ (WT) and
IL11Ra-/- (KO) uterus at time points following artificial
decidualization was determined using the normalization
and analysis functions of the statistical language R [26]
and the add-on package Statistics for Microarray Analysis
[27]. For each time point, the red and green background-
corrected intensities (R and G) from 4 slides were read
into R using the read.genepix and init.data commands.
The stat.ma function was used to calculate the log-ratios of
expression (M = log2R - log2G) and average log-intensity
(A = (log2R + log2G)/2) for each spot, and to normalize
the red and green channels relative to one another usingReproductive Biology and Endocrinology 2004, 2:76 http://www.rbej.com/content/2/1/76
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print-tip loess normalization [28]. Diagnostic MA plots of
each slide were used to determine the effectiveness of this
normalization method in adjusting for sources of varia-
tion arising from dye bias and print-tip effects.
Given the indirect dye swap design [29] of these experi-
ments, log-ratio values were reversed in the dye-swapped
slides and the log-ratio for each gene was calculated as the
difference of two independent log ratios from the equa-
tion log (KO/WT) = log (KO/reference) - log (WT/refer-
ence). Differentially expressed genes were identified by
considering a univariate testing problem for each gene
and then correcting for multiple testing using adjusted p-
values [30]. The function stat.lm [31] was used to fit a lin-
ear model for each gene to the series of 4 arrays and esti-
mate the average fold change and a standard deviation for
each gene, taking into account the pattern of dye swaps
and duplicate spots. The stat.bay.est command [31] then
computed a moderated t-statistic and B-statistic for each
gene, to give a log odds ratio of difference in mRNA
expression between IL11Ra+/+ and IL11Ra-/-. Genes with a
log odds score of greater than 3 (ie. adjusted p-value <
0.05) in both replicates were considered to be signifi-
cantly up- or down-regulated in IL11Ra-/- uterus compared
to wild type.
Real-time RT-PCR
Total RNA samples extracted from IL11Ra+/+ (n = 2) and
IL11Ra-/- (n = 2) uterus at 48 h of decidualization and used
for microarray analysis, and an additional two samples
per genotype prepared in the same way were used for val-
idation of the microarray data by real-time reverse tran-
scription polymerase chain reaction (RT-PCR). All
samples (n = 4/genotype) were further purified through
an RNeasy Spin Column (Qiagen, Valencia, CA), and
quantitated by RiboGreen Assay (Molecular Probes,
Eugene, OR) according to the manufacturer's instructions,
prior to triplicate reverse transcription reactions.
Total RNA (1 µg) was reverse transcribed at 46 C for 1.5 h
in 20 µl reaction mixture using 100 ng random hexanucle-
otide primers and 6 IU AMV reverse transcriptase (Roche,
Castle Hill, Australia) in the presence of cDNA synthesis
buffer (Roche), 1 mM dNTPs (Roche), 10 mM dithiothre-
itol (Roche) and 10 IU ribonuclease inhibitor (RNasin;
Promega, Annandale, Australia). The resulting cDNA mix-
tures were heated at 95 C for 5 min before storage at -20
C in small volumes to avoid freeze-thawing. Negative con-
trols were performed by omission of reverse transcriptase.
For real-time quantification of selected mRNA transcript
levels in IL11Ra+/+ and IL11Ra-/- uterus at 48 h of decidu-
alization, PCR was carried out using a Roche LightCycler.
Prior to LightCycler analysis, standard cDNA for each gene
of interest was generated using a PCR Express block cycler
(Thermo Hybaid Instruments, Franklin, MA). A 1 µl aliq-
uot of RT product was amplified in a total volume of 40 µl
using 4 µl of 10 × PCR Reaction Buffer (100 mM Tris-HCl,
15 mM MgCl2, 500 mM KCl, pH 8.3; Roche), 62.5 µM
dNTPs (Gibco-BRL, Life Technologies), 10 pmol sense
and antisense primers (Sigma Genosys, Castle Hill, NSW,
Australia; Table 1) and 2.5 IU Taq DNA polymerase
(Roche). The PCR amplification consisted of a hot start at
95 C for 5 min followed by 35 – 40 cycles of denaturation
at 94 C for 50 sec, annealing at x C (see annealing temper-
ature in Table 2) for 40 sec and extension at 72 C for 40
sec. The final extension was performed at 72 C for 10 min.
Optimal annealing temperature (x) and cycle number
were determined for each primer pair (Table 2). PCR
products were electrophoresed on a 1.5% agarose gel con-
taining 200 ng/ml ethidium bromide. Each single ampli-
fied product band was excised from the gel and purified
using the UltraClean GelSpin DNA Extraction Kit (Mo Bio
Laboratories, Solana Beach, CA). The cDNA concentration
was measured using a spectrophotometer and each
sequence identity confirmed at the Wellcome Trust
Sequencing Centre, Monash Medical Centre. Standard
curves for each transcript were generated using serial 1:10
dilutions of this standard cDNA using sterile water. Sam-
ples were diluted 1:10 – 1:40 prior to LightCycler analysis.
Absolute concentrations of mRNA present in IL11Ra+/+
and IL11Ra-/- uterus at 48 h of decidualization were calcu-
lated relative to the standard curve, and adjusted for 18S
rRNA expression levels.
Table 1: Oligonucleotide primers used in real-time RT-PCR. Primer pairs previously published – COL3A1 [82], BGN [83], SPARC [84] 
and NID1 [85].
Target Sense primer sequence Antisense primer sequence
COL3A1 5'-GGCTCCTGGTGAGCGAGGACG-3' 5'-CCCATTTGCACCAGGTTCTCC-3'
BGN 5'-CGGGACCTTGCTGTCTTCTC-3' 5'-CCCGGCAAGAACCTGAAAG-3'
SPARC 5'-AGAAGGCCTTTAGCCCTCTGC-3' 5'-ACTTTGCGGATACGGTTGTC-3'
NID1 5'-AGCTTCTATGATCGTACGGACATCAC-3' 5'-GTAAAGAACTGTAGACCATCTTCAGG-3'
18S 5'-CGGCTACCACATCCAAGGAA-3' 5'-GCTGGAATTACCGCGGCT-3'Reproductive Biology and Endocrinology 2004, 2:76 http://www.rbej.com/content/2/1/76
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The cDNA template (triplicate RT reactions for each of 4
animals per genotype; 4 µl) was added to sterile capillaries
to a total volume of 20 µl containing SYBR Green I,
dNTPs, Taq DNA polymerase and reaction buffer (Light-
Cycler FastStart DNA Master SYBR Green I Kit; Roche),
supplemented with 5 pmol of specific sense and antisense
primers (Table 1) and an optimal concentration of MgCl2
(Table 2). An initial denaturing step was performed for 10
min at 95 C, prior to 35 – 40 cycles of 95 C for 15 sec, x C
for 5 sec and 72 C for 10 sec. Fluorescence was monitored
continuously during cycling at the end of each elongation
phase. At the end of each program, melting curve analysis
confirmed the specificity of the reaction products.
Statistical analysis of real-time RT-PCR data
Triplicate RT reactions for each sample, the standard curve
and a no RT negative control were analyzed in the same
run, and each run was repeated once. A mean value for the
initial target concentration of each sample was calculated
using the fit points function of the LightCycler software.
The mean concentration of 18S rRNA for each sample was
used to control for RNA input, as it is considered a stable
housekeeping gene and was not altered in expression
between  IL11Ra+/+ and  IL11Ra-/- uterus. Following nor-
malization, levels of RNA for COL3A1, BGN, SPARC and
NID1 in IL11Ra-/- compared to wild type were statistically
analysed using the paired t-test function of GraphPad
Prism 3.0 (GraphPad Software, San Diego, CA). A two-
tailed p value of less than 0.05 was considered a signifi-
cant difference.
Immunohistochemistry
To confirm differential expression of collagen III, bigly-
can, SPARC and nidogen-1 at the protein level, immuno-
histochemistry was carried out on transverse sections of
IL11Ra+/+ and IL11Ra-/- uterus collected at 48 h of decidu-
alization, using specific antibodies (n = 5 mice per geno-
type, n = 3 sections per mouse). The morphology and
cellular localization of artificial decidualization in
IL11Ra+/+ and  IL11Ra-/- uterus was also determined by
immunostaining for the decidual marker desmin [32].
Primary antibodies used were rabbit anti-mouse collagen
type III (Abcam #ab7778, Cambridge, UK) at 5 µg/ml,
rabbit anti-mouse biglycan (LF-159 [33], gift from Dr.
Larry Fisher, Matrix Biochemistry Unit, National Institutes
of Health, Bethesda, MD) at 1:1000 dilution of whole
serum, goat anti-mouse SPARC (Santa Cruz Biotechnol-
ogy #sc13326, Santa Cruz, CA) at 5 µg/ml, rat anti-mouse
entactin/nidogen-1 (Lab Vision-NeoMarkers #RT797P,
Fremont, CA) at 15 µg/ml and goat anti-mouse desmin
(Santa Cruz) at 200 µg/ml. Secondary antibodies were
biotinylated swine anti-rabbit immunoglobulin G (IgG,
DAKO, Glostrup, Denmark; 1:200), horse anti-goat IgG
(Vector Laboratories, Burlingame, CA; 1:100) and rabbit
anti-rat IgG (DAKO; 1:200). For collagen III, SPARC,
nidogen-1 and desmin, negatives were performed using a
matching concentration of non-immune IgG of the spe-
cies in which the primary antibody was raised; rabbit IgG
(DAKO), goat IgG (R&D Systems, Minneapolis, MN) or
rat IgG (DAKO). For biglycan, negatives were performed
using a matching dilution of normal rabbit serum
(Sigma). Mouse lung (collagen III and biglycan) and kid-
ney (nidogen-1 and SPARC) were used as positive control
tissues, and a section from a single block was included in
each staining run for quality control. For collagen III and
SPARC immunolocalization, all dilutions and washes
were carried out in high salt Tris-buffered saline (HS-TBS,
300 mM NaCl, 5 mM TrisHCl) with 0.6 % Tween 20. TBS
(150 mM NaCl, 5 mM TrisHCl) with 0.6% Tween was
used for nidogen-1, TBS/0.3% Tween for biglycan and HS-
TBS/0.1% Tween for desmin.
Five micron sections of Carnoy's-fixed (for collagen III
and biglycan immunolocalization) or formalin-fixed (for
SPARC, nidogen-1 and desmin) uterus were mounted on
poly-L-lysine-coated glass slides, deparaffinized and rehy-
drated through a series of graded ethanols. In an humidi-
fied chamber at 25 C, sections were incubated for 10 min
in 3% hydrogen peroxide to block endogenous peroxidase
activity, then for 30 min (SPARC and desmin) or 1 h (col-
lagen III, biglycan and nidogen-1) in 10% serum of the
species in which the secondary antibody was raised
(swine, horse or rabbit; Sigma) and 2% mouse serum in
one of the above buffers. Sections were then incubated
with primary antibody or negative at 4 C overnight (colla-
gen III, biglycan, nidogen-1 and SPARC) or 30 min at 25
Table 2: Real-time RT-PCR amplification conditions for each primer pair
Primer pair PCR product size 
(bp)
Annealing temp 
(C)
No. of cycles [MgCl2] (mmol/l) Melting temp of 
PCR product (C)
COL3A1 522 64 40 3 91.2
BGN 131 58 40 5 86.3
SPARC 130 60 40 3 85.6
NID1 425 63 40 4 88.8
18S 187 60 35 4 86.8Reproductive Biology and Endocrinology 2004, 2:76 http://www.rbej.com/content/2/1/76
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C (desmin), then washed in TBS/Tween prior to second-
ary antibody incubation for 30 min (SPARC and desmin)
or 1 h (collagen III, biglycan and nidogen-1) at 25 C. Sec-
tions were again washed in TBS/Tween, then the second-
ary antibody detected using the Vectastain ABC Elite/HRP
Kit (collagen III and nidogen-1; Vector Laboratories) or
the StreptABComplex/HRP Kit (biglycan, SPARC and
desmin; DAKO) according to the manufacturer's instruc-
tions. Protein localization was visualized using the Liquid
DAB-Plus Substrate Chromogen System (DAKO), with
Harris hematoxylin (Sigma) counterstain.
Results
Artificial decidualization of IL-11Rα deficient and wild 
type uterus
Following the injection of oil into the wild type pseudo-
pregnant uterus, a progressive increase in uterine weight
was observed from 0 through to 48 h, reaching statistical
significance (p < 0.01) at the final time point (Fig. 1). In
contrast, the weight of the artificially decidualized IL11Ra-
/- uterus did not change significantly across consecutive
time points. There was therefore a statistically significant
difference (p < 0.01) in uterine weight at 48 h of artificial
decidualization between IL11Ra+/+ (96.9 +/- 9.8 mg) and
IL11Ra-/- (30.4 +/- 7.7 mg).
Differential gene expression following artificial 
decidualization
Total RNA extracted from IL11Ra+/+ and IL11Ra-/- uterus
artificially decidualized for 0, 18, 24 or 48 h (n = 2/geno-
type/time point) was used as a template for the hybridiza-
tion of NIA 15K cDNA microarrays. Figure 2 shows the
volcano style plots of the normalized data for all genes at
each time point. Each plot summarizes the data for a
series of 4 microarrays (two KO/REF and two WT/REF),
with differentially expressed genes in each replicate repre-
sented by open circles above the horizontal line (p  =
0.05). At 0 h, prior to application of the decidualizing
stimulus on day 3 of pseudopregnancy, there were no
reproducible differentially expressed genes between
IL11Ra+/+ and IL11Ra-/- (Fig. 2A,2B). Following 18 h of
decidualization (Fig 2C,2D; Table 3), five expressed
sequence tags (ESTs) were consistently upregulated 2 – 3-
fold in IL11Ra-/- uterus compared to wild type. At 24 h of
decidualization (Fig. 2E,2F; Table 4), there was one EST
upregulated 2.7-fold. Sequence information for these
ESTs is available online [34], using the AGRF ID as a
unique identifier. None of these ESTs are currently recog-
nized as sharing strong homology to any known genes. At
48 h of decidualization, 13 cDNAs showed upregulation
and 4 downregulation in IL-11Rα deficient uterus (Fig.
2G,2H; Table 5). A number of these genes have previously
described roles in the endometrium, but prior to this
study, none have been shown to interact with IL-11. The
ECM genes COL3A1, SPARC, BGN and NID1 were among
those upregulated in IL11Ra-/- uterus compared to wild
type. Transcripts representing COL3A1 and SPARC were
present at two different locations on the array, and in each
case, both sets of duplicate spots showed consistent
upregulation in the absence of IL-11Rα. There were no
genes or ESTs which were differentially expressed at more
than one time point.
Validation of gene expression by real-time RT-PCR
To confirm the altered mRNA expression of the ECM
genes COL3A1, SPARC, BGN and NID1 at 48 h of decid-
ualization, quantitative real-time RT-PCR was carried out
using the same RNA samples used in the microarray anal-
ysis, plus two additional RNA samples of each genotype,
collected in the same way. At a significance level of p <
0.05, there was no statistical difference in the abundance
of 18S rRNA (data not shown), COL3A1 (Fig. 3A), BGN
(Fig. 3B), SPARC (Fig. 3C) or NID1 (Fig. 3D) mRNA
between IL11Ra+/+ and IL11Ra-/- uterus. When only the
samples used in the microarray analysis were considered,
the difference in NID1 abundance between IL11Ra+/+
(1.13 +/- 0.12 fg/µl) and IL11Ra-/- (1.66 +/- 0.09 fg/µl)
uterus approached statistical significance at p = 0.0708.
Validation of gene expression by immunohistochemistry
Four genes found to be differentially expressed in IL11Ra-
/- uterus compared to wild type at 48 h of decidualization
were investigated at the protein level by immunohisto-
chemistry using specific antibodies. Decidualizing and
fully decidualized cells were identified in adjacent
Uterine weight following artificial decidualization Figure 1
Uterine weight following artificial decidualization. 
Weight (mg +/- SEM) of uterine horns at times following arti-
ficial decidualization of IL11Ra+/+ (open bars) and IL11Ra-/- 
(shaded bars) littermates. ** p < 0.01.
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Gene expression in IL11Ra+/+ and IL11Ra-/- uterus following artificial decidualization Figure 2
Gene expression in IL11Ra+/+ and IL11Ra-/- uterus following artificial decidualization. Expression profiling of 15K 
genes between IL11Ra+/+ and IL11Ra-/- at 0 h (A, B), 18 h (C, D), 24 h (E, F) and 48 h (G, H) following the artificial induction of 
decidualization. Each volcano style plot shows the normalized log ratio (effect estimate) of IL11Ra-/- compared to wild type for 
each gene from a series of 4 microarrays, plotted against the log odds of differential expression. A, C, E, G represent the first 
replicates, and B, D, F, H the second dye-swapped replicates. Genes with log odds of differential expression greater than 3 (ie. 
adjusted p-value < 0.05, above horizontal line) are represented by open circles, and COL3A1, BGN, SPARC and NID1 are 
labeled in G and H. Only those genes with log odds of differential expression greater than 3 in both replicates were considered 
differentially expressed, as described in Methods.
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Table 3: Differentially expressed genes in IL11Ra-/- uterus compared to wild type at 18 h of decidualization
AGRF ID GenBank 
Accession
UniGene 
Cluster
Gene Fold Change P Value
H3084H06 BG070211 Mm.25335 EST: Cdc14b: CDC14 cell division cycle 14 homolog B (S. 
cerevisiae)
+ 3.1 0.044
H3137G08 BG074662 Mm.197274 EST: Moderately similar to GNMSLL retrovirus-related reverse 
transcriptase homolog – mouse retrotransposon (M. musculus)
+ 3.0 0.046
H3123E03 BG073512 Mm.197252 EST: Weakly similar to TLM MOUSE TLM PROTEIN (M. 
musculus)
+ 2.9 0.047
H3073G12 BG069200 Mm.328026 EST: Transcribed sequence with moderate similarity to protein 
ref:NP_083358.1 (M. musculus); RIKEN cDNA 5830411J07
+ 2.5 0.038
H3082G05 AU014577 Not assigned EST + 2.1 0.032
Table 4: Differentially expressed genes in IL11Ra-/- uterus compared to wild type at 24 h of decidualization
AGRF ID GenBank 
Accession
Unigene 
Cluster
Gene Fold Change P Value
H3091F10 BG064439 Mm.182580 EST: Transcribed sequence with weak similarity to protein 
ref:NP_081764.1 (M. musculus); RIKEN cDNA 5730493B19
+ 2.7 0.027
Table 5: Differentially expressed genes in IL11Ra-/- uterus compared to wild type at 48 h of decidualization
AGRF ID GenBank 
Accession
Unigene 
Cluster
Gene Fold Change P Value
H3012B10 BG063737 Mm.28870 45S pre rRNA gene + 4.2 0.002
H3133G03 BG074327 Mm.147387 Procollagen III alpha-1 (COL3A1) + 3.0 0.010
H3124H10 BG073709 Mm.147387 Procollagen III alpha-1 (COL3A1) + 2.7 0.011
H3116A04 BG072874 Mm.35439 Secreted acidic cysteine rich glycoprotein (SPARC/osteonectin/
BM-40)
+ 2.4 0.010
H3152F04 BG075853 Mm.22699 Selenoprotein P plasma 1 (SEPP1) + 2.3 0.004
H3023A11 BG064718 Mm.21228 EST: RIKEN cDNA 2610101J03 gene; expressed sequence 
C79684
+ 2.2 0.038
H3024A05 BG064802 Mm.35439 Secreted acidic cysteine rich glycoprotein (SPARC/osteonectin/
BM-40)
+ 2.2 0.027
H3128D02 BG073888 Mm.77432 Thioredoxin interacting factor (VDUP1) + 2.2 0.003
Hs.ALAD BC000977 Hs.1227 Aminolevulinate delta dehydratase (ALAD) + 2.0 0.028
H3127D03 BG073809 Mm.2608 Biglycan (BGN/PGI) + 1.8 0.010
H3025E04 BG064933 Mm.4691 Nidogen-1 (NID1/entactin) + 1.8 0.007
H3129D02 BG073972 Mm.2137 Transcriptional regulator SIN3 yeast homolog B + 1.7 0.014
H3078E09 BG069642 Mm.27816 Hexosaminidase B (HEXB) + 1.7 0.013
H3101C10 BG071626 Mm.161419 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) - 1.6 0.015
H3122C04 BG073406 Mm.68999 EST: RIKEN cDNA 9430015G10 gene - 1.6 0.036
H3116E07 BG072919 Mm.172198 EST: Weakly similar to GNMSLL retrovirus-related reverse 
transcriptase homolog – mouse retrotransposon (M. musculus)
- 2.0 0.032
H3144C05 BG075183 Mm.337732 EST - 2.1 0.014Reproductive Biology and Endocrinology 2004, 2:76 http://www.rbej.com/content/2/1/76
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sections by immunostaining for the intermediate filament
protein desmin, well characterized as a marker for decid-
ual transformation [32].
Microarray data showing highly significant and reproduc-
ible increases in COL3A1 and BGN mRNA levels in
IL11Ra-/- uterus were reflected in increased staining inten-
sity for collagen III (Fig. 4A,4B,4C,4D) and biglycan (Fig.
4E,4F,4G,4H) in IL11Ra-/- uterus (Fig. 4B,4D,4F,4H) com-
pared to wild type (Fig. 4A,4C,4E,4G). In both IL11Ra-/-
and wild type uterus, collagen III and biglycan were pri-
marily localized to the outer connective tissue and
smooth muscle cells of the myometrium, with diffuse
staining in the cytoplasm of decidualized stromal cells
(Fig. 4D,4H inserts). Interstitial compartments underlying
luminal and glandular epithelium and surrounding blood
vessels also showed strong immunoreactivity for both
proteins, while the epithelial cells were negative. In the
absence of IL-11Rα, stronger staining for collagen III was
particularly evident underlying luminal epithelium and in
the ECM surrounding decidualizing stromal cells. There
was a consistent absence of subluminal collagen III stain-
ing on the antimesometrial side of the uterus in wild type
animals, an effect not seen in IL11Ra-/- littermates (Fig.
4C,4D). There was also a clear difference in the localiza-
tion of biglycan staining underlying luminal epithelium,
with strong staining at the mesometrial pole of the uterus
in wild type animals and no preferential localization to
either pole in IL11Ra-/- animals (Fig 4E,4F,4G). Biglycan
staining surrounding glands was much more intense in
IL11Ra-/- uterus (Fig. 4H) compared to wild type (Fig. 4G
insert).
Quantitative real-time RT-PCR for extracellular matrix components Figure 3
Quantitative real-time RT-PCR for extracellular matrix components. Quantitative real-time RT-PCR for (A) 
COL3A1, (B) BGN, (C) SPARC and (D) NID1. Circled data points indicate samples used in the cDNA microarray analysis, and 
horizontal lines the mean of each genotype. Absolute values for mRNA abundance were normalized to that of 18S rRNA.
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Immunohistochemistry for extracellular matrix components Figure 4
Immunohistochemistry for extracellular matrix components. Immunohistochemical staining of wild type (A, C, E, G, 
I, K, M, O, P, Q, S) and IL11Ra-/- (B, D, F, H, J, L, N, R, T) uterus at 48 h of decidualization using specific antibodies for collagen 
III (A, B, C, D), biglycan (E, F, G, H), nidogen-1 (I, J, K, L), SPARC (M, N, O, P) and desmin (Q, R, S, T). Negative controls using 
a matching concentration of non-immune IgG (collagen III, nidogen-1, SPARC and desmin) or normal serum (biglycan) in place 
of the primary antibody are inset in A, B, E, F, I, J, M, N, Q and R. Black squares on A and B indicate the antimesometrial pole 
magnified in C and D. Abbreviations: connective tissue (ct), myometrium (my), mesometrial pole (m), antimesometrial pole 
(am), luminal epithelium (le), glandular epithelium (ge), decidualized stromal cell (dsc), non-decidualized stromal cell (sc), blood 
vessel (bv), glycocalyx (gly). Scale bar = 50 µm (A, B, E, F, I, J, M, N, Q and R are at the same magnification; C, D, G and P are 
at the same magnification; H, K, L, O, S, T and inset in G are at the same magnification).
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While no detectable differences were observed in the over-
all intensity of immunostaining for nidogen-1 (Fig.
4I,4J,4K,4L) or SPARC (Fig. 4M,4N,4O,4P) in IL11Ra-/-
uterus compared to wild type, the localization of these
proteins has not previously been described in the decidu-
oma of wild type or IL11Ra-/- mice. In both genotypes,
nidogen-1 was localized to the cytoplasm of decidual cells
(Fig. 4K) and glandular epithelial cells (Fig. 4L), the base-
ment membrane underlying luminal and glandular epi-
thelium and surrounding blood vessels (Fig. 4L). The
cellular localization of SPARC was more similar to that of
collagen III and biglycan, with strong staining in the outer
connective tissue and myometrium (Fig. 4M,4N). Strong
SPARC staining was also detected in the cytoplasm of
decidualized and non-decidualized stromal cells (Fig.
4O), endothelial cells (Fig. 4P), and at the glycocalyx of
luminal and glandular epithelium (Fig. 4P).
Desmin immunostaining revealed a reduction in the over-
all extent of decidualization in IL11Ra-/- uteri at 48 h fol-
lowing the induction of deciduomata (IL11Ra+/+: Fig.
4Q,4S; IL11Ra-/-: Fig. 4R,4T), with an absence of second-
ary decidualization. Desmin-positive decidual cells were
detected in all artificially decidualized uteri, indicating
that the surgical induction of decidualization was success-
ful in all cases.
Discussion
Interleukin-11 is one of only a few molecules known to be
critical for decidualization in mice. This study has demon-
strated for the first time that IL-11 regulates changes in the
uterine extracellular matrix that are necessary for decidu-
alization. The application of cDNA microarray analysis
has revealed that lack of IL-11 signalling in IL11Ra-/- mice
results in differences in mRNA expression compared to
wild type during artificial decidualization. Each of the
ECM molecules investigated further in this study, collagen
III, biglycan, nidogen-1 and SPARC, showed protein
expression patterns consistent with a role in decidualiza-
tion, with immunostaining in endometrial stromal cells
and their surrounding matrices. Collagen III and biglycan
were more abundant during defective decidualization in
IL11Ra-/- uterus, both at the mRNA and protein levels. This
indicates that the cellular processes of decidualization
including proliferation, differentiation, signal
transduction and apoptosis may be facilitated by
decreased expression of these matrix molecules.
As well as providing a dynamic structural framework, the
ECM of the endometrium interacts with its associated
cells to mediate critical processes, including adhesion,
migration and differentiation (reviewed in [35]). Growth
factor availability can also be regulated by binding to ECM
components [36]. Collagens, elastin, structural glycopro-
teins (eg. fibronectin, laminin, SPARC and nidogen), pro-
teoglycans (eg. biglycan) and glycosaminoglycans are the
major components of endometrial matrix, and can act as
ligands for both cell-cell and cell-matrix interactions [37].
Decidualization of endometrial stromal cells is associated
with dramatic changes in matrix composition, including
the phagocytosis and digestion of collagen fibrils, an
increase in collagen fibril diameter [38], deposition of
basement membrane proteins [39], the synthesis and
secretion of sulfated glycosaminoglycans into the extracel-
lular space and a decrease in elastic fibrils surrounding
mature decidual cells [1]. Disruptions to the composition
of uterine ECM during decidualization may be responsi-
ble for the failure of implantation in IL11Ra-/- mice.
While the microarray data showed consistent, reproduci-
ble upregulation of COL3A1, BGN, SPARC and NID1 in
IL11Ra-/- compared to wild type uterus, this effect was not
statistically significant when real-time RT-PCR was used as
an alternative quantitation method. Many factors may
contribute to discrepancies between cDNA microarray
and real-time RT-PCR data. There are major differences in
the approach to mRNA quantitation used by the two tech-
niques. Using cDNA microarray, the mean fluorescence
intensity ratio for each gene in IL11Ra-/- or  IL11Ra+/+
uterus was calculated relative to a reference pool, and the
ratio of IL11Ra-/- to IL11Ra+/+ determined by the use of
computational algorithms. When quantitating the same
mRNA species by real-time RT-PCR, a standard curve of
known concentration was used to infer the absolute abun-
dances of mRNA in the IL11Ra-/- and IL11Ra+/+ samples,
which were then normalized for RNA input.
Real-time RT-PCR was chosen for cDNA microarray vali-
dation in this study because it has higher sensitivity and
lower RNA requirements than Northern blot, but the lack
of agreement between the two methods is not unusual. It
is well recognized that fold change values for a given gene
may vary widely, even between two different microarray
techniques [40-43]. In using real-time RT-PCR to evaluate
microarray data, Rajeevan et al [44] found that the major-
ity of the array data were qualitatively accurate, but it was
not possible to consistently validate genes showing less
than a 4-fold difference on the array. Each of the genes
examined in this study showed less than a 3-fold differ-
ence. It is not known how well array data correlates overall
with data from RT-PCR or any other mRNA quantitation
method [45], further complicating the interpretation of
conflicting results.
There are a number of compelling arguments both for and
against conducting corroborative studies for microarray
data, and there is good evidence that the data is highly
reliable when the experimental design and statistical anal-
ysis is sound [46]. In assessing the validity of the microar-
ray data in this study, it is important to note thatReproductive Biology and Endocrinology 2004, 2:76 http://www.rbej.com/content/2/1/76
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immunostaining for both collagen III and biglycan pro-
tein confirmed the differential expression seen by micro-
array analysis. This is striking, given that changes in
protein expression detected by tissue microarray have
been found to correlate with the mRNA change less than
50% of the time [45]. Given the cellular heterogeneity of
the uterus, the localization of cell-specific expression is
essential in extending microarray data on whole uterus to
the investigation of decidualization. Neither SPARC nor
nidogen-1 proteins were altered in expression by the
absence of IL-11 signaling, but there may well be a delay
between the mRNA and corresponding protein changes.
This would not have been detected by using samples col-
lected at the same time point for both mRNA and protein
analyses.
For each of the genes examined, upregulation during
defective decidualization in IL11Ra-/- uterus is supported
by existing data in the literature. Collagen III is a fibrillar
collagen with known roles in differentiation and
migration [47], and together with collagen I forms the
structural support for the endometrium during the estab-
lishment of pregnancy [48]. Consistent with a role in
decidualization, collagen III is both secreted and phagocy-
tosed by mouse decidual cells [49], and secreted by first
trimester decidual cells in the human [50]. The reduced
number of collagen fibrils surrounding endometrial stro-
mal cells in early pregnancy [51] may facilitate decidual
transformation and blood vessel development [52]. This
decrease has previously been detected primarily in the
subepithelial endometrial stroma at day 4 [53]. In the rat,
low levels of collagen III have been reported in the pri-
mary decidual zone, with much higher concentrations in
the outer stroma and myometrium as decidualization
progresses [54]. This is consistent with immunohisto-
chemical data obtained for wild type mice in this study,
showing very low intensity staining in the antimesome-
trial decidua, and higher intensity in the outer compart-
ments of the uterus.
During the human menstrual cycle, collagen III immu-
nostaining is higher in the proliferative compared to the
secretory phase [55], indicating that downregulation and/
or metabolism and redistribution of collagen III occurs
with the onset of endometrial receptivity. Compared to
proliferative phase endometrium, the ratio of collagen III
to collagen I is decreased in decidual cells [56]. Aplin et al
[55] observed changes in collagen III distribution from
dense fibrils in the proliferative phase to matrix channels
between decidual cells in the secretory phase. This may be
involved in maintaining tissue integrity as the level of
hydration increases, and in supporting movement of leu-
kocytes through the tissue [57]. Defects in any of these
processes in IL11Ra-/- mice could contribute to impaired
decidualization.
Using microarray analysis, the mRNA encoding procolla-
gen III α1 (COL3A1) has been previously shown to
decrease in abundance in the mouse uterus at estrus [58],
and between days 3.5 and 5.0 of gestation [59], and to
increase following ovariectomy in the rat [60]. Together
with data from this study showing increased COL3A1
mRNA and mature collagen III protein in IL11Ra-/- uterus
at 48 h of decidualization, it appears that successful decid-
ualization involves downregulation of COL3A1
transcription.
Biglycan is a small leucine-rich proteoglycan, which binds
to type I [61] and type V collagen fibrils, transforming
growth factor-β [62] and tumour necrosis factor-α [63] in
vitro. Its function in ECM has not been well defined, but
biglycan is thought to be involved in the control of cell
migration [64]. In the wild type mouse uterus, there is low
endometrial biglycan expression post-implantation [65].
Biglycan mRNA expression has been shown by
oligonucleotide microarray to be downregulated in the
secretory compared to the proliferative phase of the men-
strual cycle in human endometrium [66,67], coincident
with the window of implantation. As defective deciduali-
zation in IL11Ra-/- mouse uterus was associated with the
upregulation of biglycan mRNA, the activity of this prote-
oglycan in the ECM may inhibit the decidual response.
Decidual cells are known to express nidogen-1 as part of
the pericellular basement-membrane laid down during
decidualization [39]. The main function of nidogen in the
basement-membrane is to connect networks of collagen
IV and laminin [68], but nidogen also binds perlecan
[69], fibulins [70] and fibronectin [71]. Changes in
nidogen mRNA levels have been reported during the
establishment of the placenta in the mouse, with in situ
hybridization revealing highly restricted expression in
decidual and maternal endothelial cells [72]. This study
has now shown much earlier nidogen-1 protein expres-
sion in the decidual cells, glandular epithelial cells and
epithelial basement membrane of the artificially induced
deciduoma, and indicated aberrant increased expression
of the NID1 gene during defective decidualization.
SPARC (osteonectin/BM-40) is described as a matricellu-
lar glycoprotein, in that it binds to both cells and ECM to
regulate cell-matrix interactions [73]. Like other matricel-
lular proteins, SPARC can bind and alter the activity of
cytokines and induce the expression of proteinases and
their inhibitors [74]. SPARC is often expressed in tissues
undergoing cell proliferation, migration and ECM remod-
eling [75], so it is not surprising that substantial expres-
sion of SPARC has been observed in human decidua [76].
Differences in immunostaining intensity have been asso-
ciated with the degree of decidualization, with the
strongest staining seen in the cytoplasm of decidualizingReproductive Biology and Endocrinology 2004, 2:76 http://www.rbej.com/content/2/1/76
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cells, decreasing as decidualization progresses [76]. Fully
decidualized cells were found to express SPARC pericellu-
larly, indicating a role in mediating interactions of decid-
ual cells with their surrounding matrix. Binding of SPARC
to a number of ECM components, including collagen III
and nidogen, may contribute to the structural integrity of
the tissue [77]. It could therefore be hypothesized that
during normal decidualization, SPARC, collagen III and
nidogen-1 are coordinately downregulated to allow loos-
ening of the tissue in preparation for trophoblast inva-
sion. In both models of IL-11Rα deficiency [7,8],
implantation sites have increased rather than decreased
numbers of invading trophoblast giant cells. This patho-
logical invasion is thought to occur subsequent to failure
of decidualization, highlighting the importance of tight
regulation of ECM components in normal decidual
function.
Using mRNA and protein expression studies alone, it is
not possible to determine whether IL-11 affects ECM mol-
ecule expression directly or indirectly. The presence of
STAT binding sites in the promoters for COL3A1, BGN,
NID1 and SPARC would confirm that a direct interaction
is possible, but would not establish that the interaction is
occurring in the uterus during decidualization. Given that
IL-11 is a secreted cytokine with autocrine and paracrine
activity, a direct effect on ECM molecule transcription
would be dependent on coincident expression patterns of
the ECM molecules, IL-11 and its receptors. Maximal
expression of IL-11 and IL-11Rα mRNA has been reported
in the predecidual and decidual cells of the mouse
implantation site by in situ hybridization [7]. Expression
of gp130 mRNA is detectable in the glandular epithelium
from days 3 – 7, and in decidual cells from day 5 [78].
Given that the ECM molecules investigated in this study
are more widely expressed in the uterus, it is likely that
regulation by IL-11 is indirect.
Indirect effects of IL-11 on ECM composition could be
mediated by matrix metalloproteinases (MMPs) and/or
their inhibitors. Despite their presence on the NIA 15K
microarray, differential expression was not observed for
MMP-2, MMP-9, TIMP-2, or TIMP-3 in the IL11Ra-/- uterus
compared to wild type. Previous in vitro studies have indi-
cated that IL-11 inhibits MMP-1 and -3 protein in human
synovium [79], and enhances the ability of mouse osteob-
lasts to synthesize MMPs responsible for the degradation
of collagen I [80]. IL-11 does not influence the activity of
stromelysin in human chondrocytes [13], or induce
MMP-2, -7 or -9 in human endometrial epithelial or stro-
mal cells [81], but tissue inhibitor of metalloproteinases
(TIMP)-1 is known to be induced by IL-11 in vitro [13].
While not directly supporting a role in ECM degradation,
these interactions suggest that IL-11 is involved in
regulating the balance between MMP and TIMP activity in
the tissue.
Conclusions
This investigation of the downstream targets of IL-11 dur-
ing mouse decidualization has uncovered previously
unknown interactions between IL-11 and uterine ECM
composition. Dysregulation of collagen III, biglycan,
nidogen-1 and SPARC in the absence of IL-11 signaling at
the time of decidualization may indicate essential func-
tions for these molecules during the implantation process
in mice. Functional studies using mouse and human
endometrium may further clarify the mechanisms of IL-
11 action on the ECM during this critical time in embryo
implantation. By elucidating the role of IL-11 regulated
genes in decidualization, future work may identify poten-
tial new targets for the manipulation of human fertility.
Authors' contributions
CAW carried out all the experimental work and statistical
analysis and drafted the manuscript. LR provided the het-
erozygote IL11Ra+/- breeding pairs. LAS conceived of the
study, participated in its design and coordination and
helped to draft the manuscript. All authors read and
approved the final manuscript.
Acknowledgments
The authors would like to thank Dr Melissa Brasted for her assistance with 
the surgical procedures, and Prof Terry Speed, Dr Gordon Smyth and Dr 
Rory Wolfe for their contributions to the planning of the microarray exper-
iments and subsequent data analysis using R.
References
1. Abrahamsohn PA, Zorn TM: Implantation and decidualization in
rodents. J Exp Zool 1993, 266:603-628.
2. Krehbiel RH: Cytological studies of the decidual reaction in
the rat during early pregnancy and in the production of
deciduomata. Physiol Zool 1937, 10:212-233.
3. Enders AC, Schlafke S: Cytological aspects of trophoblast-uter-
ine interaction in early implantation. Am J Anat 1969, 125:1-29.
4. Finn CA, Keen PM: The induction of deciduomata in the rat. J
Embryol Exp Morphol 1963, 11:673-682.
5. De Feo VJ: Decidualization. In In: Cellular Biology of the Uterus Edited
by: Wynn RM. Amsterdam: North Holland; 1967:192-291. 
6. Finn CA, Hinchliffe JR: Reaction of the mouse uterus during
implantation and deciduoma formation as demonstrated by
changes in the distribution of alkaline phosphatase. J Reprod
Fertil 1964, 53:331-338.
7. Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, Begley CG:
Infertility in female mice lacking the receptor for inter-
leukin-11 is due to a defective uterine response to
implantation. Nat Med 1998, 4:303-308.
8. Bilinski P, Roopenian D, Gossler A: Maternal IL-11R alpha func-
tion is required for normal decidua and fetoplacental devel-
opment in mice. Genes Dev 1998, 12:2234-2243.
9. Nandurkar HH, Robb L, Tarlinton D, Barnett L, Kontgen F, Begley
CG: Adult mice with targeted mutation of the interleukin-11
receptor (IL11Ra) display normal hematopoiesis. Blood 1997,
90:2148-2159.
10. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara RM,
Leary AC, Sibley B, Clark SC, Williams DA: Molecular cloning of a
cDNA encoding interleukin-11, a stromal cell-derived lym-
phopoietic and hematopoietic cytokine. Proc Natl Acad Sci U S A
1990, 87:7512-7516.Reproductive Biology and Endocrinology 2004, 2:76 http://www.rbej.com/content/2/1/76
Page 14 of 15
(page number not for citation purposes)
11. Baumann H, Schendel P: Interleukin-11 regulates the hepatic
expression of the same plasma protein genes as interleukin-
6. J Biol Chem 1991, 266:20424-20427.
12. Kawashima I, Ohsumi J, Mita-Honjo K, Shimoda-Takano K, Ishikawa
H, Sakakibara S, Miyadai K, Takiguchi Y: Molecular cloning of
cDNA encoding adipogenesis inhibitory factor and identity
with interleukin-11. FEBS Lett 1991, 283:199-202.
13. Maier R, Ganu V, Lotz M: Interleukin-11, an inducible cytokine
in human articular chondrocytes and synoviocytes, stimu-
lates the production of the tissue inhibitor of
metalloproteinases. J Biol Chem 1993, 268:21527-21532.
14. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T: Molec-
ular cloning and expression of an IL-6 signal transducer,
gp130. Cell 1990, 63:1149-1157.
15. Barton VA, Hall MA, Hudson KR, Heath JK: Interleukin-11 signals
through the formation of a hexameric receptor complex. J
Biol Chem 2000, 275:36197-36203.
16. Aaronson DS, Horvath CM: A road map for those who don't
know JAK-STAT. Science 2002, 296:1653-1655.
17. Yang YC, Yin T: Interleukin (IL)-11-mediated signal
transduction. Ann N Y Acad Sci 1995, 762:31-41.
18. Dimitriadis E, Salamonsen LA, Robb L: Expression of interleukin-
11 during the human menstrual cycle: coincidence with stro-
mal cell decidualization and relationship to leukaemia inhib-
itory factor and prolactin. Mol Hum Reprod 2000, 6:907-914.
19. Cork BA, Li TC, Warren MA, Laird SM: Interleukin-11 (IL-11) in
human endometrium: expression throughout the menstrual
cycle and the effects of cytokines on endometrial IL-11 pro-
duction in vitro. J Reprod Immunol 2001, 50:3-17.
20. Karpovich N, Chobotova K, Carver J, Heath JK, Barlow DH, Mardon
HJ: Expression and function of interleukin-11 and its receptor
alpha in the human endometrium.  Mol Hum Reprod 2003,
9:75-80.
21. Dimitriadis E, Robb L, Salamonsen LA: Interleukin-11 advances
progesterone-induced decidualization of human endome-
trial stromal cells. Mol Hum Reprod 2002, 8:636-643.
22. Koumantaki Y, Matalliotakis I, Sifakis S, Kyriakou D, Neonaki M, Goy-
menou A, Koumantakis E: Detection of interleukin-6, inter-
leukin-8, and interleukin-11 in plasma from women with
spontaneous abortion.  Eur J Obstet Gynecol Reprod Biol 2001,
98:66-71.
23. Chen H-F, Lin C-Y, Chao K-H, Wu M-Y, Yang Y-S, Ho H-N: Defec-
tive production of interleukin-11 by decidua and chorionic
villi in human anembryonic pregnancy. J Clin Endocrinol Metab
2002, 87:2320-2328.
24. Chomczynski P, Sacchi N: Single-step method of RNA isolation
by acid guanidinium thiocyanate-phenol-chloroform
extraction. Anal Biochem 1987, 162:156-159.
25. Access to NIA 15K Mouse cDNA Clone Set  [http://
lgsun.grc.nia.nih.gov/cDNA/15k.html]
26. The R Project for Statistical Computing  [http://www.r-
project.org]
27. R Package: Statistics for Microarray Analysis  [ h t t p : / /
www.stat.berkeley.edu/users/terry/zarray/Software/smacode.html]
28. Smyth GK, Speed T: Normalization of cDNA microarray data.
Methods 2003, 31:265-273.
29. Yang YH, Speed T: Design issues for cDNA microarray
experiments. Nat Rev Genet 2002, 3:579-588.
30. Dudoit S, Yang YH, Callow MJ, Speed TP: Statistical methods for
identifying differentially expressed genes in replicated cDNA
microarray experiments. Statistica Sinica 2002, 12:111-139.
31. Lonnstedt I, Speed TP: Replicated microarray data.  Statistica
Sinica 2002, 12:31-46.
32. Glasser SR, Julian J: Intermediate filament protein as a marker
of uterine stromal cell decidualization.  Biol Reprod 1986,
35:463-474.
33. Fisher LW, Stubbs JT 3rd, Young MF: Antisera and cDNA probes
to human and certain animal model bone matrix noncolla-
genous proteins. Acta Orthop Scand Suppl 1995, 266:61-65.
34. NIA 15K Sequence Verification Page  [http://
lgsun.grc.nia.nih.gov/cDNA/PublicSeqVerify.html]
35. Aplin JD: Endometrial extracellular matrix. In In: The
Endometrium Edited by: Glasser SR, Aplin JD, Giudice LC, Tabibzadeh
S. London: Taylor and Francis; 2002:294-307. 
36. Ruoslahti E, Yamaguchi Y: Proteoglycans as modulators of
growth factor activities. Cell 1991, 64:867-869.
37. Reichardt LF: Composition and function of the extracellular
matrix. In In: Guidebook to the Extracellular Matrix, Anchor and Adhesion
Proteins Edited by: Kreis T, Vale R. Oxford: Oxford University Press;
1999:335-344. 
38. Zorn TM, Bevilacqua EM, Abrahamsohn PA: Collagen remodeling
during decidualization in the mouse.  Cell Tissue Res 1986,
244:443-448.
39. Wewer UM, Damjanov A, Weiss J, Liotta LA, Damjanov I: Mouse
endometrial stromal cells produce basement-membrane
components. Differentiation 1986, 32:49-58.
40. Kuo WP, Jenssen TK, Butte AJ, Ohno-Machado L, Kohane IS: Anal-
ysis of matched mRNA measurements from two different
microarray technologies. Bioinformatics 2002, 18:405-412.
41. Kothapalli R, Yoder SJ, Mane S, Loughran TP Jr: Microarray results:
how accurate are they? BMC Bioinformatics 2002, 3:22.
42. Barrett JC, Kawasaki ES: Microarrays: the use of oligonucle-
otides and cDNA for the analysis of gene expression. Drug Dis-
cov Today 2003, 8:134-141.
43. Rogojina AT, Orr WE, Song BK, Geisert EE Jr: Comparing the use
of Affymetrix to spotted oligonucleotide microarrays using
two retinal pigment epithelium cell lines.  Mol Vis 2003,
9:482-496.
44. Rajeevan MS, Vernon SD, Taysavang N, Unger ER: Validation of
array-based gene expression profiles by real-time (kinetic)
RT-PCR. J Mol Diagn 2001, 3:26-31.
45. Chuaqui RF, Bonner RF, Best CJ, Gillespie JW, Flaig MJ, Hewitt SM,
Phillips JL, Krizman DB, Tangrea MA, Ahram M, Linehan WM,
Knezevic V, Emmert-Buck MR: Post-analysis follow-up and vali-
dation of microarray experiments.  Nat Genet 2002,
32(Suppl):509-514.
46. Rockett JC, Hellmann GM: Confirming microarray data – is it
really necessary? Genomics 2004, 83:541-549.
47. Olsen BR, Ninomiya Y: Fibrillar collagens. In In: Guidebook to the
Extracellular Matrix, Anchor and Adhesion Proteins Edited by: Kreis T,
Vale R. Oxford: Oxford University Press; 1999:383-387. 
48. Teodoro WR, Witzel SS, Velosa AP, Shimokomaki M, Abrahamsohn
PA, Zorn TM: Increase of interstitial collagen in the mouse
endometrium during decidualization. Connect Tissue Res 2003,
44:96-103.
49. Zorn TM, Bijovsky AT, Bevilacqua EM, Abrahamsohn PA: Phagocy-
tosis of collagen by mouse decidual cells.  Anat Rec 1989,
225:96-100.
50. Kisalus LL, Herr JC, Little CD: Immunolocalization of extracel-
lular matrix proteins and collagen synthesis in first-trimester
human decidua. Anat Rec 1987, 218:402-415.
51. Finn CA: The biology of decidual cells. Adv Reprod Physiol 1971,
5:1-26.
52. Fainstat T: The helical collagen fibers in the uterus. IV. Extra-
cellular studies of uterus. Am J Obstet Gynecol 1964, 89:1026-1039.
53. Martello EM, Abrahamsohn PA: Collagen distribution in the
mouse endometrium during decidualization. Acta Anat 1986,
127:146-150.
54. Hurst PR, Palmay RD, Myers DB: Localization and synthesis of
collagen types III and V during remodelling and decidualiza-
tion in rat uterus. Reprod Fertil Dev 1997, 9:403-409.
55. Aplin JD, Charlton AK, Ayad S: An immunohistochemical study
of human endometrial extracellular matrix during the men-
strual cycle and first trimester of pregnancy. Cell Tissue Res
1988, 253:231-240.
56. Iwahashi M, Muragaki Y, Ooshima A, Yamoto M, Nakano R: Altera-
tions in distribution and composition of the extracellular
matrix during decidualization of the human endometrium. J
Reprod Fertil 1996, 108:147-155.
57. Bulmer JN, Sunderland CA: Bone-marrow origin of endometrial
granulocytes in the early human placental bed.  J Reprod
Immunol 1983, 5:383-387.
58. Tan YF, Li FX, Piao YS, Sun XY, Wang YL: Global gene profiling
analysis of mouse uterus during the oestrous cycle. Reproduc-
tion 2003, 126:171-182.
59. Yoshioka K, Matsuda F, Takakura K, Noda Y, Imakawa K, Sakai S:
Determination of genes involved in the process of implanta-
tion: application of genechip to scan 6500 genes. Biochem Bio-
phys Res Commun 2000, 272:531-538.
60. Wu X, Pang ST, Sahlin L, Blanck A, Norstedt G, Flores-Morales A:
Gene expression profiling of the effects of castration andPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Reproductive Biology and Endocrinology 2004, 2:76 http://www.rbej.com/content/2/1/76
Page 15 of 15
(page number not for citation purposes)
estrogen treatment in the rat uterus.  Biol Reprod 2003,
69:1308-1317.
61. Schonherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J,
Kresse H: Interaction of biglycan with type I collagen. J Biol
Chem 1995, 270:2776-2783.
62. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik
DR, Border WA, Ruoslahti E: Interaction of the small interstitial
proteoglycans biglycan, decorin and fibromodulin with
transforming growth factor beta. Biochem J 1994, 302:527-534.
63. Tufvesson E, Westergren-Thorsson G: Tumour necrosis factor-
alpha interacts with biglycan and decorin.  FEBS Lett 2002,
530:124-128.
64. Kinsella MG, Tsoi CK, Jarvelainen HT, Wight TN: Selective expres-
sion and processing of biglycan during migration of bovine
aortic endothelial cells. The role of endogenous basic fibrob-
last growth factor. J Biol Chem 1997, 272:318-325.
65. San Martin S, Soto-Suazo M, De Oliveira SF, Aplin JD, Abrahamsohn
P, Zorn TM: Small leucine-rich proteoglycans (SLRPS) in uter-
ine tissues during pregnancy in mice.  Reproduction 2003,
125:585-595.
66. Kao LC, Tulac S, Lobo S, Imani B, Yang JP, Germeyer A, Osteen K,
Taylor RN, Lessey BA, Giudice LC: Global gene profiling in
human endometrium during the window of implantation.
Endocrinology 2002, 143:2119-2138.
67. Borthwick JM, Charnock-Jones DS, Tom BD, Hull ML, Teirney R, Phil-
lips SC, Smith SK: Determination of the transcript profile of
human endometrium. Mol Hum Reprod 2003, 9:19-33.
68. Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann
H, Mann K, Timpl R, Krieg T, Engel J: Recombinant nidogen con-
sists of three globular domains and mediates binding of lam-
inin to collagen type IV. EMBO J 1991, 10:3137-3146.
69. Reinhardt D, Mann K, Nischt R, Fox JW, Chu ML, Krieg T, Timpl R:
Mapping of nidogen binding sites for collagen type IV,
heparan sulfate proteoglycan, and zinc.  J Biol Chem 1993,
268:10881-10887.
70. Sasaki T, Gohring W, Pan TC, Chu ML, Timpl R: Binding of mouse
and human fibulin-2 to extracellular matrix ligands. J Mol Biol
1995, 254:892-899.
71. Hsieh JC, Wu C, Chung AE: The binding of fibronectin to entac-
tin is mediated through the 29 kDa amino terminal fragment
of fibronectin and the G2 domain of entactin. Biochem Biophys
Res Commun 1994, 199:1509-1517.
72. Thomas T, Dziadek M: Expression of laminin and nidogen genes
during the postimplantation development of the mouse
placenta. Biol Reprod 1993, 49:1251-1259.
73. Riedlitz A, Sage EH: SPARC (osteonectin, BM40). In In: Guidebook
to the Extracellular Matrix, Anchor and Adhesion Proteins Edited by: Kreis
T, Vale R. Oxford: Oxford University Press; 1999:480-483. 
74. Bornstein P, Sage EH: Matricellular proteins: extracellular mod-
ulators of cell function. Curr Opin Cell Biol 2002, 14:608-616.
75. Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG, Sage
EH: SPARC regulates the expression of collagen type I and
transforming growth factor-beta1 in mesangial cells. J Biol
Chem 1999, 274:32145-32152.
76. Wewer UM, Albrechtsen R, Fisher LW, Young MF, Termine JD:
Osteonectin/SPARC/BM-40 in human decidua and carci-
noma, tissues characterized by de novo formation of base-
ment membrane. Am J Pathol 1988, 132:345-355.
77. Lane TF, Sage EH: The biology of SPARC, a protein that mod-
ulates cell-matrix interactions. FASEB J 1994, 8:163-173.
78. Ni H, Ding NZ, Harper MJ, Yang ZM: Expression of leukemia
inhibitory factor receptor and gp130 in mouse uterus during
early pregnancy. Mol Reprod Dev 2002, 63:143-150.
79. Hermann JA, Hall MA, Maini RN, Feldmann M, Brennan FM: Impor-
tant immunoregulatory role of interleukin-11 in the inflam-
matory process in rheumatoid arthritis. Arthritis Rheum 1998,
41:1388-1397.
80. Hill PA, Tumber A, Papaioannou S, Meikle MC: The cellular actions
of interleukin-11 on bone resorption in vitro.  Endocrinology
1998, 139:1564-1572.
81. Cork BA, Tuckerman EM, Li TC, Laird SM: Expression of inter-
leukin (IL)-11 receptor by the human endometrium in vivo
and effects of IL-11, IL-6 and LIF on the production of MMP
and cytokines by human endometrial cells in vitro. Mol Hum
Reprod 2002, 8:841-848.
82. Macauley SP, Tarnuzzer RW, Schultz GS, Chegini N, Oxford GE,
Humphreys-Beher MG: Extracellular-matrix gene expression
during mouse submandibular gland development. Arch Oral
Biol 1997, 42:443-454.
83. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg
WB: Differential effects of local application of BMP-2 or TGF-
beta 1 on both articular cartilage composition and osteo-
phyte formation. Osteoarthritis Cartilage 1998, 6:306-317.
84. Cui CY, Durmowicz M, Tanaka TS, Hartung AJ, Tezuka T, Hashimoto
K, Ko MS, Srivastava AK, Schlessinger D: EDA targets revealed by
skin gene expression profiles of wild-type, Tabby and Tabby
EDA-A1 transgenic mice. Hum Mol Genet 2002, 11:1763-1773.
85. Dong L, Chen Y, Lewis M, Hsieh JC, Reing J, Chaillet JR, Howell CY,
Melhem M, Inoue S, Kuszak JR, DeGeest K, Chung AE: Neurologic
defects and selective disruption of basement membranes in
mice lacking entactin-1/nidogen-1.  Lab Invest 2002,
82:1617-1630.